CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONALTHERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STARTRIAL

M. Østergaard, R. Van Vollenhoven, A. Rudin, M. L. Hetland, M. Heiberg, D. Nordström, M. Nurmohamed, B. Gudbjornsson, L. Midtbøll Ørnbjerg, P. Bøyesen, I. Olsen, K. Lend, K. Hørslev-Petersen, T. Uhlig, T. Sokka-Isler, G. Gröndal, S. Krabbe, J. Lindqvist, I. Gjertsson, D. GlinatsiM. C. Kapetanovic, A. B. Aga, F. Faustini, P. Parmanne, T. Lorenzen, G. Cagnotto, J. Back, O. Hendricks, D. Vedder, T. Rannio, E. Grenholm, H. M. Lindegaard, M. K. A. Ljosa, E. Brodin, A. Soderbergh, M. Rizk, E. Hermansson, L. Uhrenholt, P. Larsson, S. A. Just, G. Bakland, D. Stevens, T. B. Laurberg, E. A. Haavardsholm, J. Lampa, NORD-STAR Study Group

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberOP0058
JournalAnnals of the Rheumatic Diseases
Volume81
Issue numberSuppl. 1
Pages (from-to)38-40
Number of pages3
ISSN0003-4967
DOIs
Publication statusPublished - Jun 2022
EventAnnual European Congress of Rheumatology, EULAR 2022 - Copenhagen, Denmark
Duration: 1 Jun 20224 Jun 2022
https://www.congress.eular.org/

Conference

ConferenceAnnual European Congress of Rheumatology, EULAR 2022
Country/TerritoryDenmark
CityCopenhagen
Period01/06/202204/06/2022
Internet address

Bibliographical note

Abstract No. OP0058

Cite this